Ticker Symbol: DSGN
Design Therapeutics Inc
$20.48 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001807120
Company Profile
Design Therapeutics is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules. The company’s lead program is focused on the treatment of Friedreich ataxia, followed by a program in myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: 6005 Hidden Valley Road
Website: www.designtx.com
CEO: João Siffert
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.29
Change:
$0.02
(
0.88%)
Days Range: $2.25 - $2.34
Beta: 1.32
52wk. High: $16.63
52wk. Low: $1.94
Ytd. Change -76.90%
50 Day Moving Average: $2.40
200 Day Moving Average: $5.04
Shares Outstanding: 55986657
Valuation
Market Cap: 12.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A